DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tdrr36/the_world_market) has announced the addition of the "The World Market for Infectious Disease Diagnostic Tests" report to their offering.
Infectious diseases are among the most challenging issues facing health care delivery systems around the world today. The World Health Organisation estimates that more than 17 million people die of an infectious disease each year, with many of these acquired in hospitals. The World Market for Infectious Disease Diagnostic Tests, takes a comprehensive look at the markets for companies of testing products that can combat infectious disease threats.
The art of microorganism identification and therapy decisions is becoming increasingly more important and more complex. This provides both challenges and opportunities for infectious disease testing. The world is getting smaller and smaller - people and products are moving over country boundaries as never before.
Immigrants and visitors to countries bring with them different species of microorganisms that may require identification. Therefore highly sophisticated and versatile methodologies are required to respond for the need to identify a larger and more diversified list of pathogens. The report provides a review of trends and technological advancements in infectious disease testing in the next 5 years.
Sales and forecasts of infectious disease reagents are made through to 2017. Emerging products and markets are described; key players and strategies discussed and competitive trends are analyzed.
Specific market details are provided for the following:
- HIV Testing, Molecular and Immunoassays
- Respiratory Infecton Testing
- Immunoassays for STDs
- Immunoassays for Hepatitis
- TORCH testing
- Rapid Influenza Testing
- Rapid Malaria Testing
- Rapid HIV
- Rapid Strep A
- Rapid Hepatitis,
- Rapid STD Testing
- C. diff Testing
- E. coli Testing
- H. pylori Testing
- OTC - Home Use Testing For Infectious Disease
- Molecular HIV Testing
- Molecular Hepatitis Testing
- Molecular GC/Chlamydia Testing
- Molecular Hospital Acquired Infection Testing
- Molecular Respiratory Testing
- Organism ID Testing
- Blood Bank, Immunoassays
- Blood Bank, Molecular
- ID/AST Panels
- ID/AST Chromogenetic Media
- Sepsis Testing
The following diseases are covered in the report in detail:
- Chagas Disease
- HPV/ cervical cancer
- Diarrheal Diseases
For more information visit http://www.researchandmarkets.com/research/tdrr36/the_world_market